Literature DB >> 9225959

Chemotherapy in oesophageal cancer.

T C Kok1.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9225959     DOI: 10.1016/s0305-7372(97)90021-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.

Authors:  B L Brücher; W Weber; M Bauer; U Fink; N Avril; H J Stein; M Werner; F Zimmerman; J R Siewert; M Schwaiger
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

3.  Esophageal stenting.

Authors:  Andrew S Lowe; Maria B Sheridan
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

4.  Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.

Authors:  A van der Gaast; T C Kok; L Kerkhofs; P D Siersema; H W Tilanus; T A Splinter
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

5.  First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

Authors:  E van Meerten; F A L M Eskens; E C van Gameren; L Doorn; A van der Gaast
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.